138 related articles for article (PubMed ID: 27511357)
1. Quantitative comparison of immunohistochemical and PCR analysis of midkine expression in breast cancer types and serum midkine level.
Çetin Sorkun H; Akbulut M; Enli Y; Tepeli E; Özkan S; Erdem E
Turk J Med Sci; 2016 Jan; 46(1):219-27. PubMed ID: 27511357
[TBL] [Abstract][Full Text] [Related]
2. Immunohistochemical and quantitative competitive PCR analyses of midkine and pleiotrophin expression in cervical cancer.
Moon HS; Park WI; Sung SH; Choi EA; Chung HW; Woo BH
Gynecol Oncol; 2003 Mar; 88(3):289-97. PubMed ID: 12648577
[TBL] [Abstract][Full Text] [Related]
3. Preoperative serum midkine concentration is a prognostic marker for esophageal squamous cell carcinoma.
Shimada H; Nabeya Y; Tagawa M; Okazumi S; Matsubara H; Kadomatsu K; Muramatsu T; Ikematsu S; Sakuma S; Ochiai T
Cancer Sci; 2003 Jul; 94(7):628-32. PubMed ID: 12841873
[TBL] [Abstract][Full Text] [Related]
4. Midkine expression in human breast cancers: expression of truncated form.
Miyashiro I; Kaname T; Shin E; Wakasugi E; Monden T; Takatsuka Y; Kikkawa N; Muramatsu T; Monden M; Akiyama T
Breast Cancer Res Treat; 1997 Mar; 43(1):1-6. PubMed ID: 9065593
[TBL] [Abstract][Full Text] [Related]
5. The expression and location of midkine in gastric carcinomas of Chinese patients.
Huang Y; Cao G; Wang H; Wang Q; Hou Y
Cell Mol Immunol; 2007 Apr; 4(2):135-40. PubMed ID: 17484808
[TBL] [Abstract][Full Text] [Related]
6. Midkine as a prognostic marker for gastrointestinal stromal tumors.
Kaifi JT; Fiegel HC; Rafnsdottir SL; Aridome K; Schurr PG; Reichelt U; Wachowiak R; Kleinhans H; Yekebas EF; Mann O; Ichihara-Tanaka K; Muramatsu T; Kluth D; Strate T; Izbicki JR
J Cancer Res Clin Oncol; 2007 Jul; 133(7):431-5. PubMed ID: 17221186
[TBL] [Abstract][Full Text] [Related]
7. The clinical and prognostic significance of midkine in breast cancer patients.
Li F; Tian P; Zhang J; Kou C
Tumour Biol; 2015 Dec; 36(12):9789-94. PubMed ID: 26159850
[TBL] [Abstract][Full Text] [Related]
8. Increased serum midkine levels in autism spectrum disorder patients.
Esnafoglu E; Cirrik S
Int J Neurosci; 2018 Jul; 128(7):677-681. PubMed ID: 29164967
[TBL] [Abstract][Full Text] [Related]
9. Serum midkine concentrations and gastric cancer.
Obata Y; Kikuchi S; Lin Y; Yagyu K; Muramatsu T; Kumai H;
Cancer Sci; 2005 Jan; 96(1):54-6. PubMed ID: 15649256
[TBL] [Abstract][Full Text] [Related]
10. Expression of the heparin-binding growth factor midkine in the cerebrospinal fluid of patients with neurological disorders.
Yoshida Y; Ikematsu S; Muramatsu H; Sakakima H; Mizuma N; Matsuda F; Sonoda K; Umehara F; Ohkubo R; Matsuura E; Goto M; Osame M; Muramatsu T
Intern Med; 2008; 47(2):83-9. PubMed ID: 18195496
[TBL] [Abstract][Full Text] [Related]
11. Serum midkine levels are increased in patients with various types of carcinomas.
Ikematsu S; Yano A; Aridome K; Kikuchi M; Kumai H; Nagano H; Okamoto K; Oda M; Sakuma S; Aikou T; Muramatsu H; Kadomatsu K; Muramatsu T
Br J Cancer; 2000 Sep; 83(6):701-6. PubMed ID: 10952771
[TBL] [Abstract][Full Text] [Related]
12. [Clinical Significance of Serum Midkine in Children with Henoch-Schonlein Purpura].
Li MM; Liu N; Zhagn M; Xue HR
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2017 Feb; 25(1):181-185. PubMed ID: 28245398
[TBL] [Abstract][Full Text] [Related]
13. Midkine levels and its relationship with atherosclerotic risk factors in essential hypertensive patients.
Guzel S; S Cinemre FB; Guzel EC; Kucukyalcin V; Kiziler AR; Cavusoglu C; Gulyasar T; Cinemre H; Aydemir B
Niger J Clin Pract; 2018 Jul; 21(7):894-900. PubMed ID: 29984722
[TBL] [Abstract][Full Text] [Related]
14. Clinical significance of midkine expression in pancreatic head carcinoma.
Maeda S; Shinchi H; Kurahara H; Mataki Y; Noma H; Maemura K; Aridome K; Yokomine T; Natsugoe S; Aikou T; Takao S
Br J Cancer; 2007 Aug; 97(3):405-11. PubMed ID: 17622248
[TBL] [Abstract][Full Text] [Related]
15. The growth factor midkine may play a pathophysiological role in rheumatoid arthritis.
Shindo E; Nanki T; Kusunoki N; Shikano K; Kawazoe M; Sato H; Kaneko K; Muraoka S; Kaburaki M; Akasaka Y; Shimada H; Hasunuma T; Kawai S
Mod Rheumatol; 2017 Jan; 27(1):54-59. PubMed ID: 27163292
[TBL] [Abstract][Full Text] [Related]
16. High levels of urinary midkine in various cancer patients.
Ikematsu S; Okamoto K; Yoshida Y; Oda M; Sugano-Nagano H; Ashida K; Kumai H; Kadomatsu K; Muramatsu H; Takashi Muramatsu ; Sakuma S
Biochem Biophys Res Commun; 2003 Jun; 306(2):329-32. PubMed ID: 12804566
[TBL] [Abstract][Full Text] [Related]
17. Expression of truncated midkine in human colorectal cancers.
Miyashiro I; Kaname T; Nakayama T; Nakamori S; Yagyu T; Monden T; Kikkawa N; Nishisho I; Muramatsu T; Monden M; Akiyama T
Cancer Lett; 1996 Sep; 106(2):287-91. PubMed ID: 8844985
[TBL] [Abstract][Full Text] [Related]
18. Measuring midkine: the utility of midkine as a biomarker in cancer and other diseases.
Jones DR
Br J Pharmacol; 2014 Jun; 171(12):2925-39. PubMed ID: 24460734
[TBL] [Abstract][Full Text] [Related]
19. Diagnostic and Prognostic Value of Talin-1 and Midkine as Tumor Markers in Hepatocellular Carcinoma in Egyptian Patients.
Mashaly AH; Anwar R; Ebrahim MA; Eissa LA; El Shishtawy MM
Asian Pac J Cancer Prev; 2018 Jun; 19(6):1503-1508. PubMed ID: 29936723
[TBL] [Abstract][Full Text] [Related]
20. Co-expression of midkine and pleiotrophin predicts poor survival in human glioma.
Ma J; Lang B; Wang X; Wang L; Dong Y; Hu H
J Clin Neurosci; 2014 Nov; 21(11):1885-90. PubMed ID: 25001988
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
